We are navigating political interference, institutional instability, and growing uncertainty across the cancer research ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

A Stage 4 cancer survivor is grateful for a 'lifesaving' clinical trial, but experts are wary over potential federal funding ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, ...

More and better kinds of screening as well as new, more targeted treatments are making breast cancer less deadly.

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

This innovative approach challenges the standard treatment path for many cancer patients, which typically includes surgery followed by chemotherapy and radiation. For patients facing difficult ...

From 2010 to 2020, breast cancer deaths among women ages 20-49 declined significantly across all breast cancer subtypes and racial/ethnic groups, with marked declines starting after 2016, according to ...

Scientists have developed a new, ready-made way to fight acute myeloid leukemia and other blood cancers that looks promising.

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...